Aquestive Therapeutics, Inc. (NASDAQ:AQST) has been given a consensus recommendation of “Buy” by the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month target price among analysts that have updated […]
